Large-scale drug waste, particularly in intravenous (IV) medication distribution, is an ongoing problem in health care settings,1 and often includes discarded IV medications that have been prepared for possible use during surgery that can expire if not used within hours.2 This not only impacts the efficacy of pharmacy operations but also contributes to escalating healthcare costs. Explore how pharmacy managers are prioritizing waste reduction, enhancing operational efficiency, and ensuring steady medication supply amid drug shortages.3 Uncover valuable insights on improving patient outcomes while curbing escalating healthcare costs in this special report now.
This is intended for U.S. healthcare professionals only. 
Rx Only.

Vial2Bag Advanced® 20mm Admixture Device: Prioritizing Waste Reduction in IV Medication Distribution

Download Our Special Report for Insights On:

Read time :  clock 3 minutes

The need for drug waste minimization in the hospital setting.The need for drug waste minimization in the hospital setting.

Vial2Bag Advanced® 20mm Admixture Device: Factors affecting waste in IV drug distribution. Factors affecting waste in IV drug distribution.

Methods for reducing drug waste for providers and pharmacists. Methods for reducing drug waste for providers and pharmacists.

 Vial2Bag Advanced® 20mm Admixture Device: Cost Reduction and Operational Efficiency in IV Medication Distribution

References:

  1. Barbariol F, Deana C, Lucchese F, et al. Evaluation of drug wastage in the operating rooms and intensive care units of a regional health service. Anesth Analg. 2021;132(5):1450-1456.
  2. Abbasi G, Gay E. Impact of sterile compounding batch frequency on pharmaceutical waste. Hosp Pharm. 2017;52(1):60-64.
  3. Bekker CL, Gardarsdottir H, Egberts ACG, et al. Pharmacists’ activities to reduce medication waste: an international survey. Pharmacy (Basel). 2018;6(3):94

 

Captcha

Captcha

The Vial2Bag Advanced® 13mm and 20mm admixture devices are 510(k) cleared by the United States Food and Drug Administration (FDA). The use of the Vial2Bag Advanced® 13mm and 20mm admixture devices should not be interpreted as modifying, extending, or superseding a drug manufacturer's labeling recommendations for storage and expiration dating, unless otherwise limited by USP <797> compounding standards. Refer to drug manufacturer's labeling and use instructions for recommendations, USP <797>, and applicable institution policy for shelf life and sterility information of reconstituted product and admixture device compatibility. Compatibility of the Vial2Bag Advanced® 13mm and 20mm admixture devices with all drug products has not been confirmed. Do not use the Vial2Bag Advanced® 13mm and 20mm admixture devices with lipids. Failure to follow the instructions provided may result in inadequate medication reconstitution, dilution, and/or transfer, possibly leading to overdose or underdose and/or delay in therapy. Products shown are for INFORMATION purposes only and may not be approved for marketing in specific regions. Please contact your West Pharmaceutical Services, Inc. (West) representative for product availability.

Vial2Bag Advanced® 20mm Admixture Device: Prioritizing Waste Reduction in IV Medication Distribution